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 104 CO
RR
EC
TEProstate cancer continues to be the most frequently diagnosed neoplasm, and the second leading cause of cancer-relatedmortality in men. Oxidative stress may enhance prostatic carcinogenesis. Manganese superoxide dismutase (MnSODQ2) isthe only known superoxide scavenger in mitochondria. It plays a key role in antioxidant defense as mitochondria are
important for oxidative metabolism coupled to the electron transport chain and oxidative phosphorylation and hence, ROS
production. AT!C single nucleotide substitution, resulting in a Val!Ala change at position 9 (Ala-9Val), which alters the
secondary structure of the protein, has been noted to affect transport of MnSOD into the mitochondria. We have determined
the MnSOD genotype in 85 prostate cancer cases and 151 control subjects. Ala-9Val polymorphism was determined using
real time polymerase chain reaction (PCR) amplification with fluorescently labeled primers. No significant difference was
found in prostate cancer susceptibility in the subjects with Ala/Ala and Val/Ala genotype compared with Val/Val genotype
(Odds ratio (OR), 1.3; 95% confidence interval (95% CI), 0.69–2.42; p¼ 0.416). We did not observe an association of the
MnSOD genotype or allele frequency between subgroups of cases divided by disease status (aggressive vs. non-aggressive
prostate cancer). However, in the analyses stratified by the age at diagnosis we have observed that men homozygous for Ala
had a 5.2-fold increased risk of early-onset prostate cancer (under age of 65) compared to men homozygous for Val allele
(p¼ 0.05). These data suggest that Ala/AlaMnSOD genotype in theMacedonian population could have an influence on early
onset of prostate cancer, but no impact on the subsequent development of the disease. Copyright # 2008 John Wiley &
Sons, Ltd. 105 
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 117 INTRODUCTION
Prostate cancer continues to be the most frequently
diagnosed neoplasm and the second leading cause of
cancer-related mortality in men.1 Oxidative stress,
along with the formation of reactive oxygen species
(ROS), is likely to play a role in the etiology of
prostate cancer.2 ROS are generated by normal
metabolic processes in vivo and can initiate a cascadeReceived 7 February 2008
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